Aqvesme 100 MG Oral Tablet
- RxCUI
- 2730666
- RxNorm name
- Aqvesme 100 MG Oral Tablet
- Display name
- Aqvesme 100 MG Oral Tablet
- Full name
- Aqvesme 100 MG Oral Tablet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:49
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AQVESME | MITAPIVAT | Agios Pharmaceuticals, Inc. | 1d4e2654-1636-0d01-e063-6394a90af303 | 2026-08-27 | Boxed warning, Warnings, Adverse reactions | 2730666 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 1d4e2654-1636-0d01-e063-6394a90af303 | Aqvesme 100 MG Oral Tablet [PSN] · mitapivat 100 MG Oral Tablet [Aqvesme] [SBD] · Aqvesme 100 MG Oral Tablet [SY] | 3 | 4 | These highlights do not include all the information needed to use AQVESME safely and effectively. See full prescribing information for AQVESME . AQVESME ™ ( mitapivat ) tablets for oral use Initial U.S. Approval: 2022 | 20260422 |